Trial
NCT02934932
A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
Otsuka America Pharmaceutical
Condition
Post Traumatic Stress Disorder
Intervention
Brexpiprazole
Why stopped
Terminated due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-05